Category: Diseases & Conditions
Diseases & Conditions market research reports by IMARC Services Pvt. Ltd.
-
In-vivo CRO Market Report by Type (Rodent, Non-Rodent), GLP Type (Non-GLP, GLP Toxicology), Indication (Autoimmune/Inflammation Conditions, Pain Management, Oncology, CNS Conditions, Diabetes, Obesity, and Others), and Region 2025-2033
The global in-vivo CRO market size reached USD 5.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 9.8 Billion by 2033, exhibiting a growth rate (CAGR) of 6.76% during 2025-2033. The growing prevalence of chronic diseases worldwide and the increasing R&D expenditure by ... Read More
-
Clinical Nutrition Market Report by Product (Infant Nutrition, Parental Nutrition, Enteral Nutrition), Route of Administration (Oral, Enteral, Parenteral), Application (Cancer, Malnutrition, Metabolic Disorders, Gastrointestinal Disorders, Neurological Disorders, and Others), End User (Pediatric, Adults, Geriatric), and Region 2025-2033
The global clinical nutrition market size reached USD 55.8 Billion in 2024. Looking forward, the market is expected to reach USD 104.6 Billion by 2033, exhibiting a growth rate (CAGR) of 7.2% during 2025-2033. There are various factors that are driving the market, which include increasing prevalence ... Read More
-
Prostate Cancer Treatment Market Report by Drug Type (Chemotherapy, Biological Therapy, Hormone Therapy, and Others), Distribution Channel (Hospitals Pharmacies, Drug Stores and Retail Pharmacies, Online Pharmacies), and Region 2025-2033
The global prostate cancer treatment market size reached USD 8.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 12.4 Billion by 2033, exhibiting a growth rate (CAGR) of 4.9% during 2025-2033. The increasing prevalence of the disease, advancements in personalized medici ... Read More
-
Biomarkers Market Report by Product (Consumables, Services, Software), Type (Efficacy Biomarkers, Safety Biomarkers, Validation Biomarkers), Disease (Cancer, Cardiovascular Disorders, Neurological Disorders, Immunological Disorders, Renal Disorders, and Others), Application (Diagnostics, Drug Discovery and Development, Personalized Medicine, and Others), End User (Pharmaceutical and Biotechnology Companies, Diagnostic and Research Laboratories, Hospitals and Specialty Clinics, and Others), and Region 2025-2033
The global biomarkers market size reached USD 89.4 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 249.4 Billion by 2033, exhibiting a growth rate (CAGR) of 10.8% during 2025-2033. The rising prevalence of chronic diseases, ongoing developments in biotechnology and geno ... Read More
-
Women's Health Diagnostics Market Report by Type (Diagnostic Devices, Diagnostic Tests), Application (Breast Cancer, Infectious Disease Testing, Osteoporosis Testing, Pregnancy and Fertility Testing, Sexually Transmitted Disease Testing, and Others), End User (Hospital and Diagnostics Centers, Home Care), and Region 2025-2033
The global women's health diagnostics market size reached USD 31.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 54.2 Billion by 2033, exhibiting a growth rate (CAGR) of 6.4% during 2025-2033. The market is propelled by the rising number of individuals diagnosed with ... Read More
-
Prenatal and Newborn Genetic Testing Market Report by Product Type (Consumables, Instruments), Screening (Non-invasive Prenatal Testing, Chorionic Villus Sampling, Amniocentesis, Maternal Serum Screening), Disease (Downs Syndrome, Phenylketonuria, Cystic Fibrosis, Sickle Cell Anemia), End User (Hospital, Maternity and Specialty Clinics, Diagnostic Centers), and Region 2025-2033
The global prenatal and newborn genetic testing market size reached USD 6.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 17.3 Billion by 2033, exhibiting a growth rate (CAGR) of 11.04% during 2025-2033. The market share is experiencing steady growth driven by the gro ... Read More
-
Non-Alcoholic Steatohepatitis (NASH) Market by Drug Type (Vitamin E and Pioglitazone, Ocaliva, Elafibranor, Selonsertib, Cenicriviroc, and Others), Disease Cause (Hypertension, Heart Disease, High Blood Lipid, Type 2 Diabetes, Obesity), Sales Channel (Hospital Pharmacy, Online Providers, Retail Pharmacy), End User (Hospitals, Clinics, Homecare Settings), and Region 2025-2033
The global non-alcoholic steatohepatitis (NASH) market size reached USD 1.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 13.5 Billion by 2033, exhibiting a growth rate (CAGR) of 22.97% during 2025-2033. The rising prevalence of NASH, increasing awareness regarding ea ... Read More
-
Anti-Tuberculosis Therapeutics Market Report by Disease Type (Active TB, Latent TB, and Others), Diagnosis and Treatment (Diagnosis, Treatment), End User (Hospitals, Specialty Clinics, Homecare, and Others), and Region 2025-2033
The global anti-tuberculosis therapeutics market size reached USD 1,530.1 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 2,552.2 Million by 2033, exhibiting a growth rate (CAGR) of 5.56% during 2025-2033. The rising healthcare spending, favorable reimbursement policies ... Read More
-
Viscosupplementation Market by Type (Single Injection, Three Injection, Five Injection), Age Group (Adults, Geriatrics), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Application (Knee Osteoarthritis, Hip Osteoarthritis, Hand Osteoarthritis, and Others), End Use (Hospitals, Orthopedic Clinics, and Others), and Region 2025-2033
The global viscosupplementation market size reached USD 4.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 9.1 Billion by 2033, exhibiting a growth rate (CAGR) of 7.05% during 2025-2033. The increasing prevalence of osteoporosis and osteoarthritis (OA) and the shifting ... Read More
-
Systemic Lupus Erythematosus (SLE) Drugs Market by Drug Class (Antimalarials Drugs, Non-Steroidal Anti-Inflammatory Drugs (NSAIDS), Cytotoxic and Immunosuppressive Drugs, Biologics, and Others), Mode of Delivery (Intravenous, Subcutaneous, Oral), and Region 2025-2033
The global systemic lupus erythematosus (SLE) drugs market size reached USD 2.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 4.7 Billion by 2033, exhibiting a growth rate (CAGR) of 5.54% during 2025-2033. The increasing number of patients suffering from SLE, rising p ... Read More
-
Respiratory Diagnostics Market Report by Product and Service Type (Instruments and Services, Assays and Reagents, Services and Software), Test Type (Mechanical Tests, Obstructive Sleep Apnoea (OSA) Diagnostic Tests, Imaging Tests, Traditional Diagnostic Tests, Molecular Diagnostic Tests, and Others), Disease (Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease (COPD), Lung Cancer, and Others), End-User (Hospitals, Clinics, Reference and Clinical Laboratories, and Others), and Region 2025-2033
The global respiratory diagnostics market size reached USD 8.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 15.5 Billion by 2033, exhibiting a growth rate (CAGR) of 6.43% during 2025-2033. The growing prevalence of respiratory diseases, rising healthcare expenditure, ... Read More
-
Hepatitis Diagnostic Tests Market Report by Test Type (Blood Tests, Imaging Test, Liver Biopsy), and Region 2025-2033
The global hepatitis diagnostic tests market size reached USD 6.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 9.0 Billion by 2033, exhibiting a growth rate (CAGR) of 4.23% during 2025-2033. The market is experiencing robust growth, driven by the rising prevalence of ... Read More
-
H1N1 Vaccines Market Report by Vaccine Type (Intramuscular, Intranasal, Intradermal), Market Type (Public, Private), and Region 2025-2033
The global H1N1 vaccines market size reached USD 3.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 5.6 Billion by 2033, exhibiting a growth rate (CAGR) of 4.03% during 2025-2033. The increasing healthcare concerns, significant medical advancements, improving healthcar ... Read More
-
Deep Brain Stimulation Market Report by Stimulation Type (Subthalamic DBS, Globus Pallidus DBS, Thalamic DBS, Pedunculopontine Nucleus DBS), Product (Single Channel Deep Brain Stimulator, Dual Channel Deep Brain Stimulator), Application (Parkinson's Disease (PD), Epilepsy, Dystonia, Obsessive Compulsive Disorder (OCD), and Others), End-User (Hospitals, Ambulatory Surgical Centers, Neurological Centers, and Others), and Region 2025-2033
The global deep brain stimulation market size reached USD 1.4 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 2.8 Billion by 2033, exhibiting a growth rate (CAGR) of 7.91% during 2025-2033. The rising occurrence of various motor and neurological disorders among the mass ... Read More
-
Cephalosporin Market Report by Generation (First Generation, Second Generation, Third Generation, Fourth Generation, Fifth Generation), Route of Administration (Injection, Oral), Application (Respiratory Tract, Skin Infection, Ear Infection, Urinary Tract Infection, Sexually Transmitted Infection, and Others), and Region 2025-2033
The global cephalosporin market size reached USD 19.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 24.8 Billion by 2033, exhibiting a growth rate (CAGR) of 2.45% during 2025-2033. The market is experiencing steady growth driven by increasing antibiotic-resistant infe ... Read More
-
Cardiac Biomarkers Market Report by Type (Troponins (T and I), Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Brain Natriuretic Peptide (BNPs) or NT-proBNP, Ischemia Modified Albumin (IMA), and Others), Location of Testing (Laboratory Testing, Point of Care Testing), Application (Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis, and Others), and Region 2025-2033
The global cardiac biomarkers market size reached USD 11.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 22.2 Billion by 2033, exhibiting a growth rate (CAGR) of 7.22% during 2025-2033. Cardiac markers, also known as cardiac biomarkers, are released into the bloodstre ... Read More
-
Allergy Immunotherapies Market Report by Treatment Type (Subcutaneous Immunotherapy (SCIT), Sublingual Immunotherapy (SLIT)), Allergy Type (Allergic Rhinitis, Asthma, Food Allergy, Venom Allergy, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), and Region 2025-2033
The global allergy immunotherapies market size reached USD 3.4 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 7.5 Billion by 2033, exhibiting a growth rate (CAGR) of 8.29% during 2025-2033. The market is propelled by the rising prevalence of allergic conditions, increa ... Read More
-
Europe Specialty Generics Market Report by Route of Administration (Injectables, Oral, and Others), Indication (Oncology, Autoimmune Diseases, Infectious Diseases, and Others), Distributional Channel (Retail Pharmacies, Specialty Pharmacies, Hospital Pharmacies), and Region 2025-2033
The Europe specialty generics market size reached USD 21.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 42.0 Billion by 2033, exhibiting a growth rate (CAGR) of 7.34% during 2025-2033. The increasing prevalence of chronic diseases, rising demand for affordable medici ... Read More
-
Pain Management Drugs Market Report by Drug Class (NSAIDs, Anesthetics, Anticonvulsants, Antimigraine Agents, Antidepressants, Opioids, and Others), Indication (Musculoskeletal Pain, Surgical and Trauma Pain, Cancer Pain, Neuropathic Pain, Migraine Pain, Obstetrical Pain, Fibromyalgia Pain, Burn Pain, Dental/Facial Pain, Pediatric Pain, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2025-2033
The global pain management drugs market size reached USD 71.4 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 88.7 Billion by 2033, exhibiting a growth rate (CAGR) of 2.32% during 2025-2033. The market is experiencing robust growth driven by the increasing prevalence of ... Read More
-
China Genetic Testing Market Report by Test Type (Prenatal Testing, Carrier Testing, New Born Testing, Predictive/Presymptomatic Testing, Diagnostic Testing, and Others), Disease (Cancer, Down Syndrome, Thalassemia, and Others), Technology (Biochemical, Molecular, Cytogenetic), Service Provider (Hospital Based Laboratories, Independent Laboratories, Specialty Clinics), Testing Sample (Blood, Saliva, Hair, and Others) 2025-2033
The China genetic testing market size reached USD 4.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 16.4 Billion by 2033, exhibiting a growth rate (CAGR) of 13.68% during 2025-2033. Genetic testing, also known as DNA testing, provides the determination of bloodlines a ... Read More
-
Generic Drugs Market Report by Therapy Area (Central Nervous System, Cardiovascular, Dermatology, Genitourinary/Hormonal, Respiratory, Rheumatology, Diabetes, Oncology, and Others), Drug Delivery (Oral, Injectables, Dermal/Topical, Inhalers), Distribution Channel (Retail Pharmacies, Hospital Pharmacies), and Country 2025-2033
Generic Drugs Market Report by Therapy Area (Central Nervous System, Cardiovascular, Dermatology, Genitourinary/Hormonal, Respiratory, Rheumatology, Diabetes, Oncology, and Others), Drug Delivery (Oral, Injectables, Dermal/Topical, Inhalers), Distribution Channel (Retail Pharmacies, Hospital Pharmac ... Read More
-
Travel Vaccines Market Report by Composition (Mono Vaccines, Combination Vaccines), Disease (Hepatitis A, DPT, Yellow Fever, Typhoid, Hepatitis B, Measles and Mumps, Rabies, Meningococcal, Varicella, Japanese Encephalitis, and Others), and Region 2025-2033
Travel Vaccines Market Report by Composition (Mono Vaccines, Combination Vaccines), Disease (Hepatitis A, DPT, Yellow Fever, Typhoid, Hepatitis B, Measles and Mumps, Rabies, Meningococcal, Varicella, Japanese Encephalitis, and Others), and Region 2025-2033 The global travel vaccines market size reac ... Read More
-
Biosimilar Market Report by Molecule (Infliximab, Insulin Glargine, Epoetin Alfa, Etanercept, Filgrastim, Somatropin, Rituximab, Follitropin Alfa, Adalimumab, Pegfilgrastim, Trastuzumab, Bevacizumab, and Others), Indication (Auto-Immune Diseases, Blood Disorders, Diabetes, Oncology, Growth Deficiency, Female Infertility, and Others), Manufacturing Type (In-house Manufacturing, Contract Manufacturing), and Region 2025-2033
Biosimilar Market Report by Molecule (Infliximab, Insulin Glargine, Epoetin Alfa, Etanercept, Filgrastim, Somatropin, Rituximab, Follitropin Alfa, Adalimumab, Pegfilgrastim, Trastuzumab, Bevacizumab, and Others), Indication (Auto-Immune Diseases, Blood Disorders, Diabetes, Oncology, Growth Deficienc ... Read More
-
Specialty Generics Market Report by Route of Administration (Injectables, Oral, and Others), Indication (Oncology, Autoimmune Diseases, Infectious Diseases, and Others), Distribution channel (Retail Pharmacies, Specialty Pharmacies, Hospital Pharmacies), and Region 2025-2033
Specialty Generics Market Report by Route of Administration (Injectables, Oral, and Others), Indication (Oncology, Autoimmune Diseases, Infectious Diseases, and Others), Distribution channel (Retail Pharmacies, Specialty Pharmacies, Hospital Pharmacies), and Region 2025-2033 The global specialty gen ... Read More
-
Metabolomics Market Report by Product (Metabolomics Instruments, Metabolomics Bioinformatics Tools and Services), Indication (Cancer, Cardiovascular Disorders, Neurological Disorders, Inborn Errors of Metabolism, and Others), Application (Biomarker and Drug Discovery, Toxicology, Nutrigenomics, Personalized Medicine, and Others), and Region 2025-2033
Metabolomics Market Report by Product (Metabolomics Instruments, Metabolomics Bioinformatics Tools and Services), Indication (Cancer, Cardiovascular Disorders, Neurological Disorders, Inborn Errors of Metabolism, and Others), Application (Biomarker and Drug Discovery, Toxicology, Nutrigenomics, Pers ... Read More
Research Assistance
